Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Mesothelioma
Near ZIP Code:  within 100 miles of 20892
Results 1-10 of 10 for your search:
Start Over
Genetically Engineered Lymphocytes in Treating Patients with Metastatic Cancer or Cancer That Cannot Be Removed by Surgery Receiving Chemotherapy and Aldesleukin
Phase: Phase II, Phase I
Type: Treatment
Age: 18 to 66
Trial IDs: 12-C-0111, NCI-2013-01516, 1112-1139, 120111, P11928, RD-12-I-02, NCT01583686
Vaccine Therapy and Iscomatrix with or without Cyclophosphamide and Celecoxib in Treating Patients with Thoracic Malignancies or Tumors That Have Spread to the Chest Cavity
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 14-C-0053, NCI-2014-02465, 140053, P131392, NCT02054104
Pemetrexed Disodium or Observation in Treating Patients with Malignant Pleural Mesothelioma without Progressive Disease after First-Line Chemotherapy
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: CALGB 30901, NCI-2011-02023, CDR0000667496, NCT01085630
Pentostatin, Cyclophosphamide, and SS1(dsFv)-PE38 Immunotoxin in Treating Patients with Mesothelioma, Lung Cancer, or Pancreatic Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 11-C-0160, NCI-2013-01490, 110160, P10761, 8980, NCT01362790
Plicamycin in Treating Patients With Malignancies Involving the Lungs, Esophagus, Pleura, or Mediastinum That Cannot Be Removed By Surgery
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 12-C-0151, NCI-2013-01534, 120151, P12961, NCT01624090
Placebo Controlled Study of VS-6063 in Subjects With Malignant Pleural Mesothelioma
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: VS-6063-202, NCI-2013-01412, NCT01870609
Safety and Efficacy of Listeria in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: ADU-CL-02, NCI-2012-03035, NCT01675765
Vaccine Therapy and Celecoxib in Treating Patients with Lung Cancer, Esophageal Cancer, Thymic Cancers, Thoracic Sarcomas, or Malignant Pleural Mesotheliomas Undergoing Surgery
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: 11-C-0041, NCI-2013-01472, 110041, P09574, NCT01258868
Amatuximab in Treating Patients with Advanced Pancreatic, Mesothelioma, Ovarian, or Non-Small Cell Lung Cancer
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 11-C-0212, NCI-2013-01497, 009-006, 110212, P10769, NCT01413451
Comprehensive Smoking Cessation Intervention during Radiation Therapy in Aiding Smoking Cessation in Patients with Thoracic or Head and Neck Cancer
Phase: No phase specified
Type: Behavioral study
Age: 18 and over
Trial IDs: J1407, NCI-2014-01739, NA_00089912, NA_00089912 / CIR00002428, NCT02188563
Start Over